Jamal Mohammad H, Corcelles Ricard, Daigle Christopher R, Rogula Tomasz, Kroh Matthew, Schauer Philip R, Brethauer Stacy A
Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio; Department of Surgery, Kuwait University, Kuwait City, Kuwait.
Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio; Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):419-23. doi: 10.1016/j.soard.2014.09.022. Epub 2014 Oct 2.
Chronic renal disease is known to adversely affect the results of bariatric surgery. There is a paucity of literature on the safety and effectiveness of bariatric surgery on dialysis patients who are at very advanced stages in their renal disease. The objective of this study was to determine the safety and effectiveness of bariatric surgery in dialysis patients.
A retrospective review of a prospectively collected database was conducted for dialysis patients who underwent bariatric surgery between January 2006 and January 2012. Age, gender, body mass index (BMI), cause of renal failure, associated co-morbidities, type of surgery, early and late complications, and mortality were collected.
Of the 3048 patients undergoing bariatric surgery during the study period, 21 dialysis patients (.7%) were identified. Eighteen patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB), 2 patients underwent laparoscopic sleeve gastrectomy, and 1 patient underwent laparoscopic adjustable gastric banding. Mean preoperative BMI was 47.1±5.5 kg/m(2), and BMI decreased to 35.3±8.4 kg/m(2) after a mean follow-up period of 27.6 months (range = 1.4-78.0 mo). Early major complications (<30 days of surgery) occurred in 2 patients (1 anastomotic leak and 1 anastomotic stricture). Four patients had a late complication, including 1 marginal ulcer with bleeding managed endoscopically, 1 small bowel obstruction requiring laparoscopic lysis of adhesions, 1 cholecystitis requiring cholecystectomy, and 1 anastomotic stricture requiring endoscopic dilation. There was 1 death in this cohort, at 45 days after LRYGB, that was unrelated to a surgery.
Chronic renal failure requiring dialysis should not be considered a contraindication to bariatric surgery. Our experience with this patient population has shown excellent medium-term weight loss and an acceptable (albeit increased) risk/benefit ratio.
已知慢性肾病会对减肥手术的结果产生不利影响。关于减肥手术对处于肾病非常晚期阶段的透析患者的安全性和有效性的文献较少。本研究的目的是确定减肥手术在透析患者中的安全性和有效性。
对2006年1月至2012年1月期间接受减肥手术的透析患者进行前瞻性收集数据库的回顾性研究。收集年龄、性别、体重指数(BMI)、肾衰竭原因、相关合并症、手术类型、早期和晚期并发症以及死亡率。
在研究期间接受减肥手术的3048例患者中,确定了21例透析患者(0.7%)。18例患者接受了腹腔镜Roux-en-Y胃旁路术(LRYGB),2例患者接受了腹腔镜袖状胃切除术,1例患者接受了腹腔镜可调节胃束带术。术前平均BMI为47.1±5.5kg/m²,平均随访27.6个月(范围=1.4-78.0个月)后,BMI降至35.3±8.4kg/m²。2例患者发生早期主要并发症(手术<30天)(1例吻合口漏和1例吻合口狭窄)。4例患者发生晚期并发症,包括1例内镜治疗的边缘性溃疡伴出血、1例需要腹腔镜粘连松解术的小肠梗阻、1例需要胆囊切除术的胆囊炎和1例需要内镜扩张的吻合口狭窄。该队列中有1例死亡,发生在LRYGB术后45天,与手术无关。
需要透析的慢性肾衰竭不应被视为减肥手术的禁忌证。我们对这一患者群体的经验表明,中期体重减轻效果良好,风险/效益比可接受(尽管有所增加)。